After 2015’s ‘breakthrough’ year for pharma approvals, will 2016 see a dip?Roche’s MS drug is among major drugs still to come in 2016. Share XAfter 2015’s ‘breakthrough’ year for pharma approvals, will 2016 see a dip?https://pharmaphorum.com/views-and-analysis/2015-breakthrough-year-pharma-approvals-will-2016-see-dip/
European safety experts review latest hepatitis C drugsEuropean safety experts are reviewing the latest generation of hepatitis C drugs following cases of re-activation of hepatitis Share XEuropean safety experts review latest hepatitis C drugshttps://pharmaphorum.com/news/european-safety-experts-review-latest-hepatitis-c-drugs/